mutual funds hdfc charity fund for cancer cure directidcw

similar funds

ℹ️ Transactions are not allowed in non Equity schemes beyond their ActualClose date

HDFC Charity Fund For Cancer Cure Direct-IDCW

Debt: Fixed Maturity - IDCW (Close ended)

HDFC Charity Fund For Cancer Cure Direct-IDCWNAV: 10.12 as on 16 Jul, 2026

Risk levelCategoryBenchmark

Factsheet

SEBI Riskometer: LowCategory: Debt: Fixed MaturityBenchmark: NIFTY Medium Duration Index

NAV: ₹10.12+0.02%

17 Jul 2026

Similar Funds

Side-by-side comparison of HDFC Charity Fund For Cancer Cure Direct-IDCW with similar funds — trailing returns, risk metrics, AUM and expense ratio.

Period	This Fund	Category Avg	Category Rank
1Y Return	+5.91%	5.75%	8 / 36
3Y Return	—	7.49%	—
5Y Return	—	6.91%	—

Trailing annualised returns (%). Category rank: lower is better. Green = top third of category.

Please login to continue

Loading…

Period

This Fund

Category Avg

Category Rank

1Y Return

+5.91%

5.75%

8 / 36

3Y Return

—

7.49%

—

5Y Return

—

6.91%

—

Frequently Asked Questions

Which funds are similar to HDFC Charity Fund For Cancer Cure Direct-IDCW?

Funds similar to HDFC Charity Fund For Cancer Cure Direct-IDCW in the Debt: Fixed Maturity category include SBI Fixed Maturity Plan - Series 67 (1467 Days) Direct-Growth, HDFC FMP 1861D March 2022 Direct-Growth, and ICICI Prudential Fixed Maturity Plan - Series 85 10 Years Plan I Direct-Growth. These funds follow a comparable investment mandate and are benchmarked against similar indices. You can compare them in detail — across returns, risk metrics, expense ratio, and portfolio composition — using the fund comparison tool on sharpely.

What is the rank of HDFC Charity Fund For Cancer Cure Direct-IDCW in its category?

The category rank of HDFC Charity Fund For Cancer Cure Direct-IDCW is shown in the Trailing Returns section above.

How does HDFC Charity Fund For Cancer Cure Direct-IDCW's expense ratio compare to similar funds?

HDFC Charity Fund For Cancer Cure Direct-IDCW has an expense ratio of 0.03%. The peers SBI Fixed Maturity Plan - Series 67 (1467 Days) Direct-Growth has an expense ratio of 0.17% and HDFC FMP 1861D March 2022 Direct-Growth has 0.08%. Over the long term, a higher expense ratio can meaningfully drag on returns, so it is worth evaluating whether the fund's performance justifies the additional cost.

How does HDFC Charity Fund For Cancer Cure Direct-IDCW's AUM compare to similar funds?

HDFC Charity Fund For Cancer Cure Direct-IDCW has an AUM of ₹189.72 crore. The peers SBI Fixed Maturity Plan - Series 67 (1467 Days) Direct-Growth has an AUM of ₹626.93 crore and HDFC FMP 1861D March 2022 Direct-Growth has ₹504.6 crore. A large AUM can sometimes limit a fund's ability to take meaningful positions in mid and small-cap stocks, as larger trades can move prices. This is particularly relevant for funds that invest outside large caps.

Which fund has the best 3-year returns in the Debt: Fixed Maturity?

The top performing fund in the Debt: Fixed Maturity category on a 3-year basis is Nippon India Fixed Maturity Plan XLV - Series 5 Direct-Growth with a CAGR of 8.72% as of 16 Jul 2026. HDFC Charity Fund For Cancer Cure Direct-IDCW has delivered - CAGR over the same period. You can view and compare the full category ranking on sharpely.

How does HDFC Charity Fund For Cancer Cure Direct-IDCW rank in risk-adjusted returns vs peers?

The Sharpe ratio of HDFC Charity Fund For Cancer Cure Direct-IDCW is shown in the Alpha, Beta & Sharpe section on the Performance tab.

HDFC Charity Fund For Cancer Cure Direct-IDCW

Similar Funds

Similar Funds

Funds in Debt: Fixed Maturity

Funds Tracking NIFTY Medium Duration Index

Frequently Asked Questions

Funds in Debt: Fixed Maturity

Funds Tracking NIFTY Medium Duration Index

Frequently Asked Questions